TipRanks
Advertisement
Advertisement
Egetis Bolsters Finances and IP as Emcitate Nears Key FDA Decision
PremiumCompany AnnouncementsEgetis Bolsters Finances and IP as Emcitate Nears Key FDA Decision
1M ago
Is P0F a Buy, Before Earnings?
Premium
Pre-Earnings
Is P0F a Buy, Before Earnings?
1M ago
Egetis sets Q2 2026 results date as Emcitate nears key FDA decision
Premium
Company Announcements
Egetis sets Q2 2026 results date as Emcitate nears key FDA decision
2M ago
Egetis Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyEgetis Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―